When: Close <$252 with visible momentum exhaustion (RSI bullish divergence, MACD histogram compressing, declining volume on selling, hammer/engulfing candle) AND Q1 FY27 print that does not confirm the bear case

Then: Scale-in entry on capitulation with Q1 FY27 confirmation

HOLD - Do not initiate any tranche at $287. Wait for either $252 washout with exhaustion signals, insider buying confirmation, or structural reversal triggers. If forced to deploy immediately, cap at 0.75% portfolio with hard re-evaluation at $295.

• Stock down 58% from peak, trading below all three major moving averages in bearish alignment
• 10 EMA at $312.89, 50 SMA at $324.88, 200 SMA at $406.92 with price at $286.80
• MACD line at negative 8.59 with histogram expanding more negative, not contracting
• RSI at 32.9 — not oversold by 30 threshold; can remain below 30 for weeks in established downtrends
• 22% structural breakdown from late-August high of $369.92 to current $286.80 in roughly 22 trading sessions
• Target washout zone $252 (May 2026 capitulation low and 52-week low) has not been tested with momentum exhaustion
• Forward earnings multiple of 10.6x is being paid for stock with fiscal 2026 customer-growth miss and unresolved agentic AI narrative risk
• Aggressive buyback program of approximately 7% of market cap annually is mechanical authorization-based capital allocation, not equivalent to insider buying conviction signal
• ATR of $14 implies daily ranges of approximately 5%, creating risk of stop clipping in high-volatility regime
• Stop at $252 represents breaking a historically major breakdown pivot with no meaningful technical support below until prices from years ago
• Break below $252 in confirmed momentum environment opens door to fast move to $220, $200, or lower
• At 1.25% portfolio allocation, $35 loss per share if stop hit equals approximately $4.4 million loss on typical institutional book
• Valuation case will remain viable in two weeks; waiting is not 'selling low and buying high' but disciplined risk management
• Historical examples (Cisco, Intel, GE) demonstrate mean-reversion has no schedule and capital deployed early pays for the privilege
• The aggressive analyst's scale-in structure is well-designed but structure lowering cost of being wrong does not make being wrong less likely
• Conservative analyst's alternative: cap immediate deployment at 0.75% with hard re-evaluation trigger at $295 with no MACD/RSI improvement

→ vs aggressive: The $252 stop represents a major historical breakdown pivot with no meaningful technical support below; a stop-out event with volume in confirmed momentum regime opens risk to $220, $200, or lower, not a 'controlled' 12% risk

→ vs aggressive: Reading corporate buyback authorization as fundamental bottoming signal is attribution error — mechanical treasurer-executed repurchases against pre-set schedule differ fundamentally from executives betting personal net worth; programs have been underwater for years historically

→ vs aggressive: The 'fully priced in' narrative assumption cannot be verified — no quantified estimate of agentic AI SMB economics compression, no Intuit Intelligence monetization metrics, no quarterly AI attach rate cadence yet

→ vs aggressive: Valuation case (10.6x forward earnings) ignores that this multiple is being paid for a stock with active customer-growth miss and narrative attack; 'cheap' does not equal 'good entry' (Cisco, Intel precedents)

→ vs aggressive: Describing the bearish technical setup as a 'feature' rather than a momentum signal that selling has not exhausted represents conviction overriding discipline

→ vs neutral: Even the neutral analyst's 'hold and accumulate on weakness into Q4 earnings' is too permissive — would not initiate any tranche at $287; requires one of three explicit confirmations before first tranche

→ vs aggressive: A well-designed scale-in structure lowering cost of being wrong does not make being wrong less likely — 'catching this particular knife at this particular price with momentum pointing the wrong way' requires justification independent of position sizing elegance

→ vs aggressive: Capital deployed is capital at risk — 'free optionality' framing of small starter ignores opportunity cost of deploying against a setup that may break the 52-week low within days of entry

Initiate 1.0% starter tranche at $287; execute remaining tranches on confirmed triggers only; wait for Q1 FY27 earnings print before adding second tranche at $252; keep hard cap at 4%.

• Valuation metrics support entry: 10.6x forward P/E, 8.3% FCF yield, 23.6% ROE, 81% gross margins, 10-14% revenue growth, PEG under 1
• Scale-in structure correct for managing unresolved AI disruption narrative without needing to resolve it today
• Modified starter at 1.0% portfolio (midpoint of 0.75% conservative and 1.25% aggressive) reflects $14 ATR regime that magnifies path risk
• 52-week low at $252 with RSI 32.9 and MACD histogram at -5.53 represents better entry than $287 if exhaustion confirms
• Buyback ($5.4B annually) is mechanical support mechanism, not conviction indicator—no insider buying confirmed
• Q1 FY27 earnings print (~November 2026) is critical catalyst; binary event risk argues against adding second tranche pre-earnings
• Social sentiment score of 5.2/10 is neutral noise; institutional flow via buybacks and guidance is what matters
• Closing-basis stop below $252 (not intraday stop) preserves participation in capitulation reversals while exiting confirmed failures

→ vs aggressive: The 58% drawdown does not prove bear case is fully priced; market reprices as evidence arrives on AI attach rates and segment-level data—not in one haircut

→ vs aggressive: Buyback argument is structural overreach; $5.4B in program-trading buybacks proves mechanical demand support but cannot be read as management conviction without insider buying

→ vs conservative: Cisco/Intel/GE comparisons are analytically lazy—INTU has 23.6% ROE, 81% gross margins, and reaffirmed guidance vs. fundamentally different structural failures in those comps

→ vs conservative: Waiting for $252 new 52-week low or $312.89 reclaim costs $35 and $25 respectively per share on a stock already declared fundamentally cheap—the 'free option' to wait has real cost

→ vs conservative: Stopping exactly at 52-week low gets clipped on intraday tests; closing-basis stop below $252 preserves participation in reversal while exiting confirmed failures